Deltex Medical Group plc is in the April edition of the British Journal of Anaesthesia

The British Journal of Anaesthesia (BJA) has published a new study, the largest ever positive Randomised Clinical Trial (RCT) on Goal-Directed Haemodynamic Therapy(GDHT) using Deltex Medical’s ODM system. The results demonstrate that even surgical patients considered to be at

Ewan Phillips, Deltex Medical’s Chief Executive, commented: “Complications after surgery are unpleasant, expensive to treat and reduce patients’ post-operative survival. The ability to eliminate over half of these is of huge value to both patients and

Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring, this morning announced that its French distributor has been awarded a new tender to supply hospitals in Paris with CardioQ-ODM+ equipment. The Company’s French

Mid January saw Deltex supporting the EBPOM (Evidence-based perioperative medicine) organisation at its first meeting of 2018. Entitled “Current Initiatives, Research and the Role of Hemodynamic Monitoring” the event was attended by a sell-out audience of

The government should help SMEs to reward their advances with quicker mass adoption by the NHS, according to Andy Mears, Managing Director of Deltex Medical Group plc (LON:DEMG) Companies can seek grant funding or tax breaks ranging from R&D credits to the Enterprise Investment Scheme for risk

Using data from 150 of its own patients, a “top ten” U.S. hospital is to adopt Deltex’s Oesophageal Doppler Monitoring (ODM) system. Ranked in the top ten hospitals in the USA, the University Teaching Hospital is a

Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), has today announced the addition of a major new hospital in the USA. The hospital is a University Teaching Hospital in our Mid-Atlantic sales

We’ve heard and written a lot about so-called Enhanced Recovery Programs (ERP). Adoption of an ERP takes the form of a set of predefined practices designed to standardize some aspects of surgical care. The aim is to

Last month saw World Anaesthesia Day and now this month we’re also celebrating the 25th anniversary of the Royal College of Anaesthetists, which received its Royal Charter as recently as 1992. TheBritish Journal of Anaesthesia has marked

Oesophageal Doppler Monitoring (ODM) has unparalleled clinical data behind it. The evidence tells us that monitoring blood flow in real time at the levels of accuracy delivered by the ODM+ system, delivers meaningful reduction in post-operative complications associated

Interviewed about Deltex Medical Group’s new TrueVue system, Chief Exec Ewan Phillips talks about the product’s background. Specifically, he explains how the company is “changing the story” by adding best-in-class technologies to its high end oesophageal

Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), has today announced the addition of a significant new hospital account in the USA. The new account is a 600 bed teaching hospital which

Deltex Medical Group plc (LON:DEMG), the global leader in oesophageal Doppler monitoring (“ODM”) today announced the release and first sales of its new High Definition Impedance Cardiography (HD-ICG) modality in France. The Company released the French language